Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Outcomes of Locally Advanced (T3 or Greater) Prostate Cancer in Men Undergoing Robot-Assisted Laparoscopic Prostatectomy
Journal of Endourology, 08/21/09
Casey JT et al. – RALP is a feasible approach to patients with pathologically advanced PCa as 71% were without evidence of disease at 13 months postoperatively. PSM rate (20%) is comparable to previously reported open PSM rates (24–66%).
Related Articles
Transperitoneal Laparoscopic Prostatectomy Does Not Increase Small Bowel Within the Target Volume for Postoperative Radiotherapy
The Journal of Urology, 10/21/09
Relevance Score: 88%
Vessel-sealing devices safe for nerve-sparing radical prostatectomy
Urology Times, 11/06/09
Relevance Score: 87%
Laparoscopic radical prostatectomy: 10 years experience
International Braz J Urol, 11/03/09
Relevance Score: 87%
Robotic-assisted laparoscopic prostatectomy
British Journal of Cancer, 10/01/09
Relevance Score: 87%
Our Modified Technique of Total Posterior Reconstruction in Open Retropubic Radical Prostatectomy
Current Urology, 11/17/09
Relevance Score: 85%
Today in Laparoscopy...keeping you current
Receive free subspecialty "5-minute updates" via email
Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09
Optimizing the Approach for Lymph Node Dissection during Laparoscopic Radical Cystectomy
European Urology, 12/03/09
Laparoscopic orchidopexy: the easy way to go
Journal of Pediatric Surgery, 12/03/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09
Today in Surgical Technique...keeping you current
Receive free subspecialty "5-minute updates" via email
Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09
Effects of Genital Ulcer Disease and Herpes Simplex Virus Type 2 on the Efficacy of Male Circumcision for HIV Prevention: Analyses from the Rakai Trials
PLoS Medicine, 12/04/09
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: Report of two initial cases
International Journal of Urology, 12/04/09
Article Search
Sponsor


See Latest Articles


